Ratings by Goldman Sachs (Andrea Tan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/9/2026 | Arrowhead Pharma | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 1/30/2026 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Arrowhead Pharma | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 12/19/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2025 | Sagimet Biosciences Inc | SGMT | Maintain | Neutral (N/A) |
|
Details | ||
| 3/10/2025 | Arrowhead Pharma | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/3/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2025 | Tarsus Pharmaceuticals | TARS | Maintain | Neutral (N/A) |
|
Details | ||
| 1/14/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/8/2024 | Arrowhead Pharma | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 9/24/2024 | Kodiak Sciences Inc. | KOD | Maintain | Sell (N/A) |
|
Details | ||
| 8/12/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2024 | Sagimet Biosciences Inc | SGMT | Maintain | Neutral (N/A) |
|
Details | ||
| 6/28/2024 | Sagimet Biosciences Inc | SGMT | Downgrade | Neutral (Buy) |
3.94 (9.81) |
148.98% | Details | |
| 6/5/2024 | Relmada Therapeutics Inc | RLMD | Downgrade | Sell (Neutral) |
3.08 (3.25) |
5.52% | Details | |
| 6/5/2024 | Arrowhead Pharma | ARWR | New Coverage | Neutral (N/A) |
24.62 (59.19) |
140.41% | Details | |
| 6/5/2024 | Jazz Pharmaceuticals | JAZZ | New Coverage | Buy (N/A) |
105.74 (206.82) |
95.59% | Details | |
| 5/28/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Sagimet Biosciences Inc | SGMT | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2024 | Sagimet Biosciences Inc | SGMT | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | Sagimet Biosciences Inc | SGMT | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | Kodiak Sciences Inc. | KOD | New Coverage | Sell (N/A) |
3.16 (93.05) |
2844.62% | Details | |
| 11/20/2023 | Immunogen Inc. | IMGN | New Coverage | Neutral (N/A) |
15.59 (31.25) |
100.45% | Details | |
| 11/20/2023 | Krystal Biotech | KRYS | New Coverage | Buy (N/A) |
98.34 (315.30) |
220.62% | Details | |
| 11/20/2023 | Tarsus Pharmaceuticals | TARS | New Coverage | Neutral (N/A) |
17.73 (70.49) |
297.57% | Details | |
| 11/20/2023 | Iovanace Biotherapeutics | IOVA | New Coverage | Buy (N/A) |
4.40 (14.14) |
221.36% | Details | |
| 8/15/2023 | Centessa Pharmaceuticals | CNTA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Sagimet Biosciences Inc | SGMT | New Coverage | Buy (N/A) |
16.09 (3.94) |
-75.51% | Details | |
| 8/4/2023 | AbCellera Biologics | ABCL | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Centessa Pharmaceuticals | CNTA | Maintain | Neutral (N/A) |
|
Details | ||
| 1/6/2023 | Fate Therapeutics | FATE | Maintain | Sell (N/A) |
|
Details | ||
| 12/19/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2022 | AbCellera Biologics | ABCL | New Coverage | Buy (N/A) |
10.08 (12.27) |
21.73% | Details | |
| 12/15/2022 | Verve Therapeutics | VERV | New Coverage | Sell (N/A) |
22.45 (11.13) |
-50.42% | Details | |
| 12/15/2022 | Fate Therapeutics | FATE | New Coverage | Sell (N/A) |
16.37 (2.05) |
-87.48% | Details | |
| 12/5/2022 | Day One Biopharmaceuticals | DAWN | New Coverage | Buy (N/A) |
21.22 (21.53) |
1.46% | Details | |
| 11/10/2022 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2022 | Codiak Biosciences Inc. | CDAK | Maintain | Neutral (N/A) |
|
Details | ||
| 10/27/2022 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Relmada Therapeutics Inc | RLMD | Downgrade | Neutral (Buy) |
6.47 (3.08) |
-52.4% | Details | |
| 9/23/2022 | Relmada Therapeutics Inc | RLMD | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2022 | Codiak Biosciences Inc. | CDAK | Downgrade | Neutral (Buy) |
2.24 (0.06) |
-97.32% | Details | |
| 8/11/2022 | Centessa Pharmaceuticals | CNTA | Maintain | Neutral (N/A) |
|
Details | ||
| 4/27/2022 | Insmed | INSM | New Coverage | Buy (N/A) |
23.56 (95.21) |
304.12% | Details | |
| 4/27/2022 | Vor Biopharma, Inc. | VOR | New Coverage | Neutral (N/A) |
5.64 (18.20) |
222.7% | Details | |
| 2/24/2022 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/11/2022 | Codiak Biosciences Inc. | CDAK | New Coverage | Buy (N/A) |
5.34 (2.24) |
-58.05% | Details | |
| 2/11/2022 | Kodiak Sciences Inc. | KOD | New Coverage | Neutral (N/A) |
65.23 (93.05) |
42.65% | Details | |
| 2/11/2022 | Centessa Pharmaceuticals | CNTA | New Coverage | Neutral (N/A) |
10.78 (40.50) |
275.7% | Details | |
| 5/20/2021 | Relmada Therapeutics Inc | RLMD | New Coverage | Buy (N/A) |
35.43 (6.47) |
-81.74% | Details | |
| 5/20/2021 | Madrigal Pharmaceuticals | MDGL | New Coverage | Buy (N/A) |
133.48 (440.49) |
230% | Details |
